Quantum-Si’s (QSI) Buy Rating Reiterated at HC Wainwright

Quantum-Si (NASDAQ:QSI)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a note issued to investors on Tuesday, Benzinga reports. They presently have a $4.00 target price on the stock. HC Wainwright’s target price would suggest a potential upside of 403.14% from the company’s current price.

Other research analysts also recently issued research reports about the stock. Weiss Ratings upgraded shares of Quantum-Si from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday. Alliance Global Partners restated a “buy” rating on shares of Quantum-Si in a report on Friday, August 14th. Finally, Wall Street Zen raised shares of Quantum-Si from a “sell” rating to a “hold” rating in a research report on Saturday, September 12th. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $2.50.

Quantum-Si Price Performance

Shares of NASDAQ QSI opened at $0.80 on Tuesday. The company has a market cap of $174.01 million, a price-to-earnings ratio of -1.73 and a beta of 3.25. The stock’s 50-day moving average is $0.77 and its two-hundred day moving average is $0.87. Quantum-Si has a 1-year low of $0.69 and a 1-year high of $3.10.

Quantum-Si (NASDAQ:QSI) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.11) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.11). Quantum-Si had a negative return on equity of 47.12% and a negative net margin of 6,138.26%.The business had revenue of $0.34 million during the quarter, compared to analysts’ expectations of $0.30 million. Equities research analysts anticipate that Quantum-Si will post -0.47 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Quantum-Si

Several hedge funds have recently added to or reduced their stakes in QSI. IPG Investment Advisors LLC purchased a new stake in shares of Quantum-Si during the 2nd quarter worth approximately $27,000. WINTON GROUP Ltd purchased a new position in shares of Quantum-Si in the 2nd quarter valued at $67,000. Corient Private Wealth LP acquired a new stake in Quantum-Si during the 2nd quarter worth $34,000. Green Alpha Advisors LLC acquired a new stake in Quantum-Si during the 2nd quarter worth $41,000. Finally, Renaissance Technologies LLC purchased a new stake in Quantum-Si in the first quarter valued at $91,000. 39.90% of the stock is currently owned by hedge funds and other institutional investors.

About Quantum-Si

Quantum-Si Incorporated (NASDAQ:QSI) is a life sciences technology company focused on advancing proteomics, the study of proteins and their roles in biological systems. The company develops tools intended to help researchers identify and analyze proteins at the single-molecule level, supporting applications in drug discovery, translational research and precision medicine.

Its primary offering is the Platinum platform, which combines an automated instrument, proprietary sequencing technology, consumables and software for protein analysis.